TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.
01 1Transo-Pharm USA LLC
02 1Transo-Pharm Handels GmbH
03 1Rochem International Inc
04 1Comhony Biotech
05 1Shanghai Minbiotech
06 1Chunghwa Chemical Synthesis & Biotech
07 1Omgene Life Sciences Pvt. Ltd
08 1Akums Lifesciences
09 1Aurobindo Pharma Limited
10 4BrightGene Bio-Medical Technology Co.,Ltd
11 1Concord Biotech
12 1Hubei Honch Pharmaceutical
13 1Huvepharma Italia S.r.l
14 1Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
15 1Lupin Ltd
16 1Sumar Biotech
17 1Suzhou Biosyntech
18 1Xellia Pharmaceuticals ApS
19 1Yacht Bio-Technology
20 1Zhejiang Huida Biotech
01 11China
02 1Denmark
03 1Germany
04 6India
05 1Italy
06 1Taiwan
07 2U.S.A
01 6Active
02 17Blank
01 23Blank
01 23Blank
01 23Blank
Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
Comhony Biotech manufactures fermentation & semi-synthetic APIs which aim at dermatology, anti-biotics; mitochondria & memory health.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6279
Start Marketing Date : 2023-09-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-07-01
Pay. Date : 2021-05-10
DMF Number : 35428
Submission : 2021-01-04
Status : Active
Type : II
NDC Package Code : 42513-0017
Start Marketing Date : 2021-01-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-04-23
Pay. Date : 2024-01-29
DMF Number : 39378
Submission : 2024-03-27
Status : Active
Type : II
We have 20 companies offering Dalbavancin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?